Healthy Volunteers Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age30-50
SponsorAbramson Cancer Center at Penn Medicine
About this trial
The purpose of this study is to examine the role of the bacterial environments and metabolites in the early detection and prediction of ovarian cancer development. Vaginal swabs and stool samples will be collected from healthy volunteers, or those without a known ovarian cancer diagnosis or genetic ovarian cancer risk. These samples will be compared to samples from participants with increased cancer risk and ovarian cancer diagnoses.
Eligibility criteria
Qualifiers
has ovaries
Disqualifiers
genetic mutations which increase risk of ovarian cancer: BRCA1/2, BRIP1, PALB2, Lynch Syndrome (MLH1, MSH2/EPCAM, MSH6) and ATM
no genetic testing results or unknown genetic status
prior cancer diagnosis
prior cancer treatment
Trial design
Treatments tested in this trial
- Self-Administered Sample Collection
Treatment groups
50 Participants
are divided into 1 treatment groupLocations
1Abramson Cancer Center of the University of Pennsylvania19104, PhiladelphiaPennsylvania, United States
Sponsors and collaborators
Abramson Cancer Center at Penn Medicine
Lead sponsor
Source ClinicalTrials.gov